Evaluation of efficacy and safety of a herbal medicine used for the treatment of malaria

Noguchi Memorial Institute for Medical Research, Legon, Gana.
Phytotherapy Research (Impact Factor: 2.4). 06/2003; 17(6):697-701. DOI: 10.1002/ptr.1196
Source: PubMed

ABSTRACT Resistance of Plasmodium falciparum to chloroquine has been reported in several countries. Other anti-malarial drugs in use are expensive and not readily accessible to most people in malaria endemic countries. This has led to renewed interest in the development of herbal medicines that have the potential to treat malaria with little or no side effects. This study obtained a preliminary information on the safety and effectiveness of a plant decoction (AM-1), used in treating malaria. The AM-1 is formulated from Jatropha curcas, Gossypium hirsutum, Physalis angulata and Delonix regia. Patients with suspected malaria attending a herbal clinic were enrolled in the study on voluntary basis. They were hospitalized for treatment, clinical observation, biochemical and haematological monitoring, and parasite clearance while on AM-1. In addition male and female Sprague Dawley rats were used to evaluate the acute and subchronic toxicity effects of AM-1. The AM-1 eliminated malaria parasites (Plasmodium falciparum and Plasmodium malarie) from the peripheral blood of patients with malaria. In addition the AM-1 did not show any undesired effects in the patients as well as in laboratory rats. The AM-1, however, showed differential effect on the activities of selected cytochrome P450 isozymes (7-pentoxyresorufin-O-depentylation, 7-ethoxyresorufin-O-deethylation and p-nitrophenol hydroxylase) in relation to sex of the laboratory rats. These results indicate that AM-1 could be used to treat malaria. However, it could precipitate interactions with other drugs via their biotransformation and elimination. The obtained data warrant further studies in a large number of malaria subjects with monitoring for possible drug interactions.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Physalis angulata is a medicinal plant with valuable pharmacological activities. The physiology of stress in this plant can play an important role in the induction or maximization of the production of physalin F, B, D and G, bioactive secondary metabolites described as immunosuppressive, anti-malarial and anti-leishmanial agents. P. angulata was cultivated from seeds which had been previously primed in PEG 6000 solution and non-primed seeds. After 45 days, the plants were exposed to water restriction and saline stress in the field for 13 days. Seedling emergence and growth after stress treatment were assessed. Seco-steroids were quantified in leaves and stems by HPLC/PDA. The emergence rate was 14% higher in primed seeds. The types of irrigation proved to have a significant influence on the number of leaves and fruits, plant height and stem diameter, irrespective of whether the seeds were primed or not. The biomass of the fruits, stems and roots was also decreased by water restriction and saline stress. Physalin content in ethanol extracts increased in leaves, mainly after saline stress and from primed seeds. Despite the biomass reduction caused by the treatments, stress application led to an increase in the production of bioactive metabolites.
    South African Journal of Botany 09/2013; 88(191):197. DOI:10.1016/j.sajb.2013.07.025 · 1.34 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Physalis angulata L., an annual herb from the Solanaceae family, is widely used in popular medicine in tropical countries to treat a variety of diseases. Two products, (X) and (Y), were isolated from a crude CH2Cl2 extract of dried Congolese Physalis angulata L. plants and crystallized from acetone for structure elucidation. Compound (X) corresponds to a physalin B dimer acetone solvate hydrate (2C28H30O9·C3H6O·0.22H2O), while compound (Y) crystallizes as a mixed crystal containing two physalin B molecules which overlap with 5β,6β-epoxyphysalin B, also known as physalin F, and one acetone molecule in the asymmetric unit (1.332C28H30O9·0.668C28H30O10·C3H6O). Antiplasmodial activity, cytotoxic activity and selectivity indices were determined for crude extracts and the two isolated products (X) and (Y).
    Acta Crystallographica Section C Crystal Structure Communications 12/2013; 69(Pt 12):1557-62. DOI:10.1107/S010827011303117X · 0.54 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Malaria is a leading health threat for low to middle-income countries and around 1.8 billion people in the Southeast Asian region and 870 million people in the Western Pacific region remain at risk of contracting malaria. Traditional medicine/traditional healer (TM/TH) use is prominent amongst populations in low- to middle-income countries and constitutes an important issue influencing and potentially challenging effective, safe and coordinated prevention and treatment strategies around malaria. This paper presents the first critical review of literature on the use of TM/TH for malaria prevention and treatment in low- to middle-income countries in the Asia-Pacific region. A comprehensive search of English language, peer-reviewed literature reporting TM and/or TH use for malaria or among people in malaria-endemic areas in low- to middle-income Asia-Pacific countries published between 2003 and 2014 was undertaken. Twenty-eight papers reporting 27 studies met the inclusion criteria. Prevalence of TM/TH use for malaria treatment ranged from 1 to 40.1%. A majority of studies conducted in rural/remote areas reported higher prevalence of TM/TH use than those conducted in mixed areas of urban, semi-urban, rural, and remote areas. Those utilizing TM/TH for malaria are more likely to be: women, people with lower educational attainment, people with lower household income, those with farming occupations, and those from ethnic minorities (identified from only three studies). The majority of adult participants delayed seeking treatment from a health centre or conventional providers while initially practicing TH use. The most common reasons for TM/TH use for malaria across the Asia-Pacific region are a lack of accessibility to conventional health services (due to geographical and financial barriers), faith in traditional treatment, and the perception of lower severity of malaria symptoms. This review has provided crucial insights into the prevalence and profile of TM/TH use for malaria. Those managing and providing conventional programmes, treatment and care for malaria in the Asia-Pacific should remain mindful of the possible use of TM/TH amongst community members and patients.
    Malaria Journal 12/2015; 14(1):593. DOI:10.1186/s12936-015-0593-7 · 3.49 Impact Factor

Similar Publications